UNSPSC 41151741: Sirolimus test system

In this classification, a Sirolimus test system is a device intended to measure Sirolimus for clinical toxicology purposes. US FDA regulates Sirolimus test system under 21 CFR 862.3840 and under FDA product code NRP

UNSPSC 41151741 Sirolimus test system is a Commodity code that does not see active recent procurement from state and local buyers. The source documents provided span July through October 2026 and do not show any opportunities specifically tagged to this code. The lone opportunity nominally associated with the code—a Mississippi procurement (9250-27-R-RFIN-00012, due September 17, 2026) for precision X-ray equipment—carries an unrelated attachment describing environmental compliance services in New Mexico, indicating a data mismatch rather than a genuine solicitation under this code. No state or local government solicitations for sirolimus test systems, immunosuppressant drug therapeutic drug monitoring systems, or related diagnostic equipment appear in the recent opportunities log.

State and local procurement activity under this code is not currently evident. Buyers pursuing sirolimus assays and related immunosuppressant therapeutic drug monitoring typically source reagents, analyzers, or service agreements through health departments, clinical laboratories, or hospital procurement offices, but no such activity surfaced in the recent opportunity set. Without evidence of active procurement demand, pursue alternatives in higher-velocity diagnostic equipment or laboratory automation codes unless your firm has direct relationships with clinical laboratory networks or state health departments known to operate these systems.